Antiretroviral Therapy and Declining Aids Mortality in New York City
Bibliographic Data
| ID | 9096743 |
|---|---|
| Authors | Peter Messeri (0000-0001-5570-760X, Columbia University, corresponding author), Gunjeong Lee (0000-0003-0083-9343, Columbia University, corresponding author), David M Abramson (0000-0002-7846-3588, Columbia University, corresponding author), Angela A Aidala (0000-0002-4425-6935, Columbia University, corresponding author), Angela Aidala, Mary Ann Chiasson (0000-0002-4906-0667), Dorothy Jones Jessop (Columbia University) |
| Year | 2003 |
| Volume | 41 |
| Issue | 4 |
| Pages | 512-521 |
| Publication date | 2003-04-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | Medical Care (JOURNAL) |
| Journal identifiers | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Publisher | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/01.mlr.0000053230.81725.ef |
| PMID | 12665715 |
| OpenAlex | W2329654651 |
| Language | EN |
| Citations received | 12 |
| References cited | 13 |
OBJECTIVE: This study estimates the impact of Highly Active Antiretroviral Therapy (HAART) and other antiretroviral therapy combinations on reducing mortality risk for a cohort of HIV-infected persons living in New York City. MATERIALS AND METHODS: Data for this study come from the CHAIN project, an ongoing multiwave longitudinal study of HIV-infected persons is living in New York City (n = 700) initiated in 1994. The study sample is drawn from the clients of 43 medical and social service agencies and is broadly representative of New York City residents, who were aware of their positive serostatus at time of enrollment. Occurrences of deaths were obtained through routine field tracking and searches of death certificates and an online death registry. Information on other study variables was obtained through in-person interviews. A Cox proportional hazard model was applied to estimate the effects of medication on mortality risk. RESULTS: Mortality rates for the CHAIN cohort dropped steadily from a high of 131 deaths per 1000 persons/year in 1995 to 31 deaths per 1000 persons/year in 1999, with the historically low mortality rates continuing through 2000. Current use of HAART was associated with a 50% reduction in mortality risk (hazard ratio = 0.51, P <0.01). CONCLUSIONS: These results demonstrate that in the case of HAART, the therapeutic benefits of an innovative but costly medical treatment are reaching populations that traditionally have poor access to quality health care
Antiretroviral therapy · Cohort · Cohort study · Confidence interval · Environmental health · Family medicine · Hazard ratio · Human immunodeficiency virus (HIV) · Mortality rate · Proportional hazards model · Serostatus · Viral load · Demography · HIV-related health complications and treatments · HIV/AIDS Impact and Responses · HIV/AIDS Research and Interventions · Internal Medicine · Medicine · Gerontology
Accessibility of antiretroviral therapy in Ghana
Trends in Mortality Disparities by Area-Based Poverty in New York City, 1990–2010
HIV-Positive Men Sexually Active with Women
Cigarette Smoking and Mortality Among HIV-Infected Individuals in Seattle, Washington (1996–2008)
Caregiver Role Overload and Network Support in a Sample of Predominantly Low-Income, African-American Caregivers of Persons Living with HIV/Aids
Social Support, Disclosure, and Use of Antiretroviral Therapy
Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City
Housing Need, Housing Assistance, and Connection to HIV Medical Care
Trends and predictors of HIV-positive community attachment among PLWHA
Survival of Aids patients in the Southeast and South of Brazil
Effects of Quality of Life and Coping on Depression among Adults Living with HIV/Aids
Trends in Non-Hispanic White Mortality in the United States by Metropolitan-Nonmetropolitan Status and Region, 1990-2016
| Citations per year | 0.57 |
|---|---|
| Citation span | 2005 - 2019 (15) |
| Highly cited | No |